The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection

Current Opinion in Pharmacology
Kenji MaedaHiroaki Mitsuya

Abstract

The discovery of CCR5 as a HIV-1 co-receptor unfolded the cryptic and complicated process of HIV-1 cellular entry and has provided more than a few entry steps as possible modalities for effective viral intervention. The proof-of-principle has already been established for the use of entry inhibitors against HIV-1 and there is a cautious optimism that several CCR5 inhibitors might soon be added to our armamentarium for therapy of HIV-1 infection.

Citations

Nov 15, 2011·AIDS Research and Human Retroviruses·Joseph K MuriukiSamuel Khamadi
Feb 9, 2012·The Indian Journal of Medical Research·UNKNOWN Nutan, Satish K Gupta
Mar 24, 2011·Future Medicinal Chemistry·Jose J ReinaJavier Rojo
Aug 16, 2005·Expert Review of Proteomics·Oliver K BernhardAnthony L Cunningham
Mar 1, 2009·Expert Opinion on Medical Diagnostics·Andrew J LowP Richard Harrigan
Apr 26, 2006·Expert Opinion on Investigational Drugs·Priscilla BiswasGiuseppe Tambussi
Feb 6, 2008·Journal of Molecular Graphics & Modelling·Ting Wang, Yong Duan
Jan 11, 2007·Biochemical and Biophysical Research Communications·Masaki ImaiHidechika Okada
Sep 19, 2006·Seminars in Immunology·Fernando Arenzana-Seisdedos, Marc Parmentier
Mar 30, 2005·Expert Opinion on Pharmacotherapy·Adriano Lazzarin
Feb 24, 2006·Virology·Christoph SeibertThomas P Sakmar
Dec 19, 2007·Advances in Pharmacology·Julie Strizki
Nov 11, 2008·The Lancet Infectious Diseases·Blayne Cutler, Jessica Justman
Nov 23, 2006·Bioorganic & Medicinal Chemistry Letters·Rena NishizawaHiroaki Mitsuya
Feb 20, 2014·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Yasumasa Hamada
Apr 25, 2006·Chemical Biology & Drug Design·Duncan R ArmourCatherine Burt
Feb 22, 2007·Journal of Medicinal Chemistry·Esther KellenbergerDidier Rognan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.